Print

Teva Pharmaceutical Industries Limited (TEVA) Drug Halved Risk of Full-Blown Multiple Sclerosis in Vita-Salute University Study  
10/7/2009 6:49:47 AM

Bookmark and Share

Oct. 7 (Bloomberg) -- Teva Pharmaceutical Industries Ltd.’s Copaxone drug can cut the likelihood of patients progressing to full-blown multiple sclerosis almost in half, researchers said.

//-->